Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-16544

Xtr WT + dyrk1a MO, Willsey HR et al. (2020)

Experiment + Assay: Xtr WT + dyrk1a MO + NF35/36 (immunohistochemistry)
Background: Xtr.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection dyrk1a MO1 dyrk1a
 NF stage 2 (2-cell) blastomere
Conditions:
Assay Type Assay Stages Antibody
immunohistochemistry NF stage 35 and 36 to NF stage 35 and 36 Tuba4b Ab5
Anatomical Phenotypes: abnormal brain morphology , abnormal telencephalon , decreased size of the telencephalon
Source: Fig. 2 E
Article: XB-ART-57038, PubMed